Ph.D., New York University M.S., New York University A.B., Middlebury College Diplomate, American Board of Toxicology

Complementary roles of gasotransmitters CO and H2S in sleep apnea. Proc. Natl. Acad. Sci. (U.S.A), DOI: 10.1073/pnas.1620717114, 2017. Y.-J. Peng, X. Zhang, A. Gridina. I. Chupikova, D.L. McCormick, T.E. Scammell, G. Kim, C. Vasavda. J. Nanduri, G.K. Kumar, S.H. Snyder, and N. R. Prabhakar. 5MeCDDO blocks metabolic activation but not progression of breast, intestine, and tongue cancers: Is antioxidant response element a prevention target? Cancer Prev. Res., 9, 616-623, 2016. R.A. Lubet, R.R. Townsend, M. Clapper, M.M. Juliana, V.E. Steele, D.L. McCormick, and C.J. Grubbs. Preclinical evaluation of carcinogenicity using standard-bred and genetically engineered rodent models. In: A Comprehensive Guide to Toxicology in Preclinical Drug Development, 2nd Edition. A.S., Faqi (Ed.), Elsevier, 2016, pp. 273-292. D.L. McCormick. Overexpression of lipocalins and pro-inflammatory chemokines and altered methylation of PTGS2 and APC2 in oral squamous cell carcinomas induced in rats by 4-nitroquinoline-1-oxide. PLoSOne, 10: e0116285. doi:10.1371/journal.pone.0116285, 2015. X. Peng, W. Li, W.D. Johnson, K.E.O. Torres, and D.L. McCormick. Differential roles of ERα and ERβ in normal and neoplastic development in the mouse mammary gland. PLoSOne, 9: e113175, 2014. R.G. Mehta, M. Hawthorne, R.R. Mehta, K.E.O. Torres, X. Peng, D. L. McCormick, and L. Kopelovich. Inhibition of proliferation and induction of autophagy by atorvastatin in PC3 prostate cancer cells correlate with downregulation of Bcl2 and upregulation of miR-182 and p21. PLoSOne, 8: e70442. doi:10.1371/journal.pone.0070442, 2013. X. Peng, W. Li, L. Yuan, R.G. Mehta, L. Kopelovich, and D.L. McCormick. Subchronic oral toxicity and cardiovascular safety pharmacology studies of resveratrol, a naturally occurring polyphenol with cancer preventive activity. Food Chem. Toxicol., 49, 3319-3327, 2011. W.D. Johnson, R.L. Morrissey, A.L. Usborne, I. Kapetanovic, J.A. Crowell, M. Muzzio, and D.L. McCormick. Subchronic oral toxicity and metabolite profiling of the p53 stabilizing agent, CP-31398, in rats and dogs. Toxicology, 289, 141-150, 2011. W.D. Johnson, M. Muzzio, C.J. Detrisac, I.M. Kapetanovic, L. Kopelovich, and D.L. McCormick. Null activity of selenium and vitamin E as cancer chemopreventive agents in the rat prostate. Cancer Prevention Res. 3, 381-392, 2010. D. L. McCormick, K.V.N. Rao, W. D. Johnson, M. C. Bosland, R. A. Lubet, and V. E. Steele. Overexpression of COX-2 in rat oral cancers and prevention of oral carcinogenesis in rats by selective and non-selective COX Inhibitors. Cancer Prevention Res., 3, 73-81, 2010. D. L. McCormick, J. M. Phillips, T. L. Horn, W. D. Johnson, V. E. Steele, and R. A. Lubet. Integration of in vivo and in vitro approaches to characterize the toxicity of Antalarmin, a corticotrophin-releasing hormone receptor agonist. Toxicology, 248, 8-17, 2008. T. L. Horn, J. B. Harder, W. D. Johnson, P. T. Curry, R. E. Parchment, R. L. Morrissey, P. W. Mellick, K. A. Calis, P. W. Gold, K. C. Rice, C. Contoreggi, D. S. Charney, G. Cizza, E. R. Glaze, J. E. Tomaszewski, and D. L. McCormick. Chemoprevention of rat prostate carcinogenesis by 16-alpha-fluoro-5-androsten-17-one (fluasterone), a minimally androgenic analog of dehydroepiandrosterone. Carcinogenesis, 28, 398-403, 2007. D. L. McCormick, W. D. Johnson, N. M. Kozub, K. V. N. Rao, R. A. Lubet, V. E. Steele, and M. C .Bosland. Animal models for the study of childhood leukemia: considerations for model identification and optimization to identify potential risk factors. Int. J. Toxicol., 23, 149-161, 2004. D. L. McCormick and R. Kavet. (Winner of the American College of Toxicology President's Award for best paper of 2004).